Lipidil (fenofibrate) is a commonly used fibrate lipid-regulating drug with a clear effect in lowering triglycerides, but it is not suitable for everyone. Patients with severe hepatic insufficiency, gallbladder disease, and pancreatitis are populations requiring special vigilance; before medication, they must be fully evaluated by a doctor, and in some cases the drug should be contraindicated or used with caution.
Contraindicated situations: Lipidil should be contraindicated in patients with severe hepatic insufficiency, active liver disease (such as active hepatitis, decompensated cirrhosis), or persistently elevated transaminases of unknown cause.
Reason: Fenofibrate is mainly metabolized by the liver; when liver function is severely impaired, the drug accumulates, which can aggravate liver injury and even induce liver failure.
Prerequisite for medication: Liver function must be checked before medication; patients with mild to moderate abnormalities should use it with caution after evaluation by a doctor, and transaminases should be rechecked regularly during medication; once significantly elevated, the drug should be stopped.
Situations requiring caution: Patients with a history of gallbladder disease such as gallstones or cholecystitis should use it with caution. Fibrates can increase cholesterol saturation in bile, promoting the formation of cholesterol gallstones or aggravating existing stones.
Risk signals: During medication, if manifestations of biliary colic or biliary obstruction such as right upper abdominal pain, nausea, or jaundice occur, seek medical attention promptly and stop the drug if necessary.
Medication recommendations: Patients with gallbladder disease should inform the doctor of their medical history before medication, and undergo regular abdominal ultrasound monitoring during treatment; for those with confirmed gallstones and obvious symptoms, use is generally not recommended.
Pancreatitis caused by severe hypertriglyceridemia: In such patients, using fenofibrate to lower triglycerides is etiology-targeted treatment and may be used under the guidance of a doctor.
Pancreatitis caused by other reasons: Fenofibrate itself may cause pancreatitis (mostly a rare adverse reaction); those with a history of pancreatitis should use it with caution, and the doctor must weigh the benefits and risks.
Warning signals: During medication, persistent severe upper abdominal pain radiating to the back, accompanied by nausea and vomiting, should raise suspicion of pancreatitis; seek medical attention immediately.
Disclaimer:《Lipidil contraindications: Patients with severe liver dysfunction, gallbladder disease, and pancreatitis》Edited and sorted by Seagull Pharmacy's editors. Please contact us in time if there is any infringement. In addition, the suggestions for drug usage, dosage and disease mentioned in the article are only for medical staff's reference, and can not be used as any basis for medication!
Full Name:Fenofibrate、Lipidil、非诺贝特片
Reference Price:$230.00
Prescribing Information: 非诺贝特片为一种调血脂药物,主要适用于高脂血症的治疗。其通过激活过氧化物酶体增殖物激活受体α(PPARα),调节与脂质代谢相关的基因表达,从而有效降低血清总胆固醇和甘油三酯水平,并提升高密度脂蛋白胆固醇水平。 一、药品名称 非诺贝特片(Lipidil),商品名:リピディル錠,有...